A detailed history of Catalyst Funds Management Pty LTD transactions in Globus Medical Inc stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 300 shares of GMED stock, worth $25,326. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Holding current value
$25,326
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$67.08 - $73.92 $20,124 - $22,176
300 New
300 $21.5 Million
Q2 2024

Dec 17, 2024

BUY
$49.79 - $68.85 $54,769 - $75,735
1,100 Added 366.67%
1,400 $95.9 Million

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.5B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Catalyst Funds Management Pty LTD Portfolio

Follow Catalyst Funds Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Funds Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Funds Management Pty LTD with notifications on news.